Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

5AM Ventures

5AM Ventures
VC INVESTOR TYPE
Active STATUS
15 PROFESSIONALS
179 INVESTMENTS
40 PORTFOLIO
57 EXITS
Description

Founded in 2002, 5AM Ventures is an early stage venture capital firm that focuses on the life science companies solving important healthcare needs via breakthroughs in medicine and science. The firm primarily invests in drug development, product discovery platforms and medical technologies. It is based in San Francisco, California.

Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2002
Primary Investor Type
Venture Capital
Primary Office
  • 501 Second Street
  • Suite 350
  • San Francisco, CA 94107
  • United States

+1 (415) 000-0000

5AM Ventures Investments (179)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Novome Biotechnologies 09-Jan-2020 Early Stage VC 0000 Biotechnology Generating Revenue 000000 000000
00000000 19-Dec-2019 00000 00000 0000 Biotechnology Generating Revenue 000000 000000
0000 0000 00000000 17-Dec-2019 00000 00000 0000 Other Healthcare Technology Systems Startup 000000 000000
0000000 000000000 15-Oct-2019 00000 00000 0000 Energy Storage Generating Revenue 0000 0000000 00.0
0000 00000000000 10-Sep-2019 0000 00000 000 Other Healthcare Services Stealth
000000 00000000000 17-Jun-2019 00000 00000 0000 Pharmaceuticals Clinical Trials - Phase 1 000000 000000
0000000 0000000000 12-Jun-2019 00000 00000 000.00 Biotechnology Generating Revenue 0000 00000000000 00.0
000000 000000 14-May-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000 0000000 00.0
Aprea Therapeutics 19-Mar-2019 Later Stage VC 000.00 Drug Discovery Clinical Trials - General 00000 00000000 00.0
Vor Biopharma 14-Feb-2019 Early Stage VC 0000 Biotechnology Startup 0000 000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 5AM Ventures’s full profile, request a free trial.

5AM Ventures Exits (57)

Company Name Exit Date Exit Type Exit Size Status Buyers
Cabaletta Bio 25-Oct-2019 IPO 000.00 Completed
00000 000000000000 03-Oct-2019 000 0000 Completed
000000 00000000000 23-May-2019 000 0000 Completed
00000000 15-Apr-2019 0000000000: 000000 Completed
0000000 0000000000 22-Jan-2019 000000000000000000 00000 Completed
  • 00000 & 000000
000000000 01-Nov-2018 000 00 00000000 Completed
0000000 27-Sep-2018 000 00000 Completed
000000000 00000000 18-Jul-2018 000 00000 Completed
Homology Medicines 28-Mar-2018 IPO 00000 Completed
Rennovia 09-Mar-2018 Out of Business Completed
To view this investor’s complete exits history, request access »

5AM Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore 5AM Ventures‘s full profile, request access.

Request full access to PitchBook

5AM Ventures Team (58)

Name Title Deals Funds Boards Office Contact
Info
Rebecca Lucia Chief Financial Officer and Chief Operating Officer San Francisco, CA
Andrew Schwab Managing Partner & Founder 00 0 0 San Francisco, CA
Kush Parmar Ph.D Managing Partner 00 0 0 Boston, MA
John Diekman Ph.D Co-Founding Partner 00 0 0 San Francisco, CA
Scott Rocklage Ph.D Co-Founding Partner 00 0 0 Boston, MA

28 Former Team Members

You’re viewing 5 of 58 team members. Get the full list »